About Retractable Technologies
Retractable Technologies is a company based in Little Elm (United States) founded in 1989 by Thomas Shaw. The company has 227 employees as of December 31, 2024. Retractable Technologies offers products and services including VanishPoint Syringe, EasyPoint Needle, VanishPoint U-100 Insulin Syringe, EasyPoint Blood Collection Tube, and VanishPoint IV Catheter. Retractable Technologies operates in a competitive market with competitors including Owen Mumford, Flat Medical, Stable Pharma, KORU Medical Systems and NuGen MD, among others.
- Headquarter Little Elm, United States
- Employees 227 as on 31 Dec, 2024
- Founders Thomas Shaw
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Retractable Technologies, Inc.
-
Annual Revenue
$33.05 M (USD)-24.19as on Dec 31, 2024
-
Net Profit
-$11.89 M (USD)-69.54as on Dec 31, 2024
-
EBITDA
-$13.54 M (USD)-241.72as on Dec 31, 2024
-
Latest Funding Round
$27.37 M (USD), Grant
Jul 01, 2020
- Investors
-
Employee Count
227
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Retractable Technologies
Retractable Technologies is a publicly listed company on the AMEX with ticker symbol RVP in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Retractable Technologies
Retractable Technologies offers a comprehensive portfolio of products and services, including VanishPoint Syringe, EasyPoint Needle, VanishPoint U-100 Insulin Syringe, EasyPoint Blood Collection Tube, and VanishPoint IV Catheter.
Retractable syringe that prevents needlestick injuries during injections.
Needle designed for safe blood collection and reduced injury risk.
Specialized syringe for insulin with low dead space to minimize waste.
Tube with needle for secure blood sampling and safety features.
Catheter that ensures safe intravenous access and injury prevention.
Funding Insights of Retractable Technologies
Investors in Retractable Technologies
Retractable Technologies has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include USAGov.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entity focused on information and services
|
Locked | Locked | Locked |
Investor details for Retractable Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Retractable Technologies
Investment portfolio details for Retractable Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Retractable Technologies
Detailed financials for Retractable Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Retractable Technologies Comparisons
Peer comparison for Retractable Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Retractable Technologies
Retractable Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Owen Mumford, Flat Medical, Stable Pharma, KORU Medical Systems and NuGen MD, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Disposables for drug delivery and capillary blood sampling are manufactured.
|
|
| Locked | Locked | Locked |
Epidural injection syringes with pressure detection are manufactured.
|
|
| Locked | Locked | Locked |
Developer of technology to store and deliver stable drugs and vaccines
|
|
| Locked | Locked | Locked |
Infusion systems and accessories for subcutaneous drug administration are manufactured.
|
|
| Locked | Locked | Locked |
Developer of needle-free drug delivery system
|
Detailed competitors of Retractable Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Retractable Technologies
Complete news archive for Retractable Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Retractable Technologies
Retractable Technologies was founded in 1989 and raised its 1st funding round 31 years after it was founded.
Retractable Technologies is headquartered in Little Elm, United States. It is registered at Little Elm, Texas, United States.
Thomas Shaw is the current CEO of Retractable Technologies. They have also founded this company.
As of Dec 31, 2024, the latest employee count at Retractable Technologies is 227.
Annual revenue of Retractable Technologies is $33.05M as on Dec 31, 2024.
Retractable Technologies was founded in 1989 and is headquartered in Little Elm, United States. Focus is placed on the medical device sector, where safety products are developed for healthcare applications. VanishPoint Syringes are offered in multiple sizes, gauges, and lengths, with needles retracting automatically into the barrel upon plunger depression. EasyPoint retractable needles are also included, featuring automated technology for pre-removal safety to reduce injury risks.
Retractable Technologies's top competitors include KORU Medical Systems, Stable Pharma and Flat Medical.
Retractable Technologies offers VanishPoint Syringe, EasyPoint Needle, VanishPoint U-100 Insulin Syringe, EasyPoint Blood Collection Tube, and VanishPoint IV Catheter.
Yes, Retractable Technologies is publicly traded on AMEX under the ticker symbol RVP.
Retractable Technologies has 1 investor. Key investors include USAGov.
The ticker symbol of Retractable Technologies is RVP on AMEX.